MedPath

PILULES DUCASE

PILULES DUCASE

Discontinued
DIN Number

00166359

Drug Class

Human

Market Date

Dec 31, 1930

Company
HC

produits francais labs inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00166359
AIG Number0605175001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
B03AA57 FERROUS SULPHATE, COMBINATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:04.04
Health Canada Classification

ACTIVE INGREDIENTS (6)

CALUMBAActive
Strength: .4 MG
Monograph: CALUMBA
CASCARA SAGRADAActive
Strength: 1 MG
Monograph: CASCARA SAGRADA
FERROUS SULFATEActive
Strength: 5 MG
Monograph: FERROUS SULFATE
GENTIANA LUTEAActive
Strength: 3 MG
Monograph: GENTIANA LUTEA
GLYCYRRHIZA GLABRAActive
Strength: 1.5 MG
Monograph: GLYCYRRHIZA GLABRA
QUASSIAActive
Strength: 1 MG
Monograph: QUASSIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.